CoChat

HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels

Open access
Puca, Francesca, Colamaio, Marianna, Federico, Antonella, Gemei, Marica, Tosti, Nadia, Bastos, André Uchimura, Vecchio, Luigi Del, Pece, Salvatore, Battista, Sabrina, Fusco, Alfredo · 2014 · Oncotarget
Cited by 65

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

// Francesca Puca 1 , Marianna Colamaio 1 , Antonella Federico 1 , Marica Gemei 2 , Nadia Tosti 1 , André Uchimura Bastos 1 , Luigi Del Vecchio 2 , Salvatore Pece 3 , Sabrina Battista 1 and Alfredo Fusco 1 1 Istituto di Endocrinologia ed Oncologia Sperimentale - CNR e/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli “Federico II”, Naples, Italy 2 CEINGE, Biotecnologie Avanzate, Naples, Italy 3 Istituto Europeo di Oncologia, Milan, Italy Correspondence: Alfredo Fusco, email: // Sabrina Battista, email: // Keywords : HMGA1, cancer stem cells, p53, colon carcinoma, NUMB Received : March 04, 2014 Accepted : April 16, 2014 Published : April 18, 2014 Abstract High-mobility group A1 (HMGA1) proteins are architectural chromatinic proteins, abundantly expressed during embryogenesis and in most cancer tissues, but expressed at low levels or absent in normal adult tissues. Several studies have demonstrated that HMGA1 proteins play a causal role in neoplastic cell transformation. The aim of this study was to investigate the role of these proteins in the control of cancer stem cells (CSCs), which have emerged as a preferred target in cancer therapy, because of their role in cancer recurrence. We observed that HMGA1 is overexpressed in colon tumour stem cell (CTSC) lines compared to normal and colon cancer tissues. We demonstrated that HMGA1 silencing in CTSCs increases stem cell quiescence and reduces self-renewal and sphere-forming efficiency (SFE). The latter, together with the upregulation and asymmetric distribution of NUMB, is indicative of the recovery of an asymmetric division pattern, typical of normal stem cells. We further found that HMGA1 transcriptionally regulates p53, which is known to control the balance between symmetric and asymmetric divisions in CSCs. Therefore, our data indicate a critical role for HMGA1 in regulating both self-renewal and the symmetric/asymmetric division ratio in CSCs, suggesting that blocking HMGA1 function may be an effective anti-cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1914

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • NUMB controls p53 tumour suppressor activity

    Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385 · cited 1×

    “Since it has been shown that NUMB is able to interact with and stabilise p53 (31), the increased expression of NUMB observed in CTSC_shA1, concomitant with nuclear relocalisation of the protein (F.”
    Background

Show all 1 references

Cited by

Metadata

Authors
Puca, F., Colamaio, M., Federico, A., Gemei, M., Tosti, N., Bastos, A. U., Vecchio, L. D., Pece, S., Battista, S., & Fusco, A.
Venue
Oncotarget
Published
2014-04-18
Volume
5
Issue
10
Pages
3234-3245
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1682499501
Cited by
65
References
1
FWCI
4.16
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.